Form 8-K - Current report:
SEC Accession No. 0001104659-24-124881
Filing Date
2024-12-03
Accepted
2024-12-03 07:11:20
Documents
16
Period of Report
2024-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429853d1_8k.htm   iXBRL 8-K 55133
2 EXHIBIT 2.1 tm2429853d1_ex2-1.htm EX-2.1 562322
3 EXHIBIT 99.1 tm2429853d1_ex99-1.htm EX-99.1 36535
7 GRAPHIC tm2429853d1_ex99-1img001.jpg GRAPHIC 12526
  Complete submission text file 0001104659-24-124881.txt   983761

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA chrs-20241202.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20241202_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20241202_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2429853d1_8k_htm.xml XML 3697
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 241521057
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)